Release Date: July 13, 2017
Expiration date : January 13, 2018
Estimated Time to Complete Activity: 1.0 hour
CME ACCREDITATION AND DESIGNATION
The Cardiovascular Research Foundation is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Cardiovascular Research Foundation designates this activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Documentation of awarded credit is provided for participants in exchange for completed activity evaluations.
CME for MOC: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC points.
OVERVIEW
This program is geared toward the interventionalist seeking to learn more about transcatheter aortic valve replacement (TAVR). TAVR has evolved to become the standard of care in high-risk patients, and the program will explore the role of TAVR in different settings, including in low- and intermediate-risk patients and in the treatment of bicuspid aortic valves. Further, the panel will discuss low- and intermediate-risk patient outcomes, the economic implications of an expanded indication for TAVR, and the place for the cardiac surgeon in a low-risk patient TAVR procedure.
LEARNING OBJECTIVES
After viewing this program, participants will be able to:
- Describe the role of TAVR in low- and intermediate-risk patients
- Explain the role of the cardiac surgeon in low-risk TAVR procedures
- Discuss future directions for TAVR procedures, including patient and device selection
- Discuss the current status of transcatheter repair and replacement of bicuspid aortic valves
AGENDA
Going Beyond the Intermediate-Risk Patient: The New Boundaries for Transcatheter Therapy
Michael J. Reardon, MD
How Many Patients Would Qualify for TAVI If All Intermediate-Risk Patients Would Be Treated With TAVR?
Christopher U. Meduri, MD
How to Meet the Logistical Challenges of a Rapidly Growing Program
Nicolas M. Van Mieghem, MD
Leveraging the TAVR Experience Into TMVR: Similarities and Differences for the Heart Team
Brij Maini, MD
TARGET AUDIENCE
This activity is designed for interventional cardiologists, cardiac surgeons, clinical cardiologists, vascular medicine specialists, and other health care professionals.
ACTIVITY EVALUATION
Evaluation by questionnaire will address content, presentation, possible bias, and future educational needs.
DISCLOSURE STATEMENT
It is the policy of the Cardiovascular Research Foundation to ensure balance, independence, objectivity, and scientific rigor in all of its sponsored educational activities. Commercial support from industry does not influence educational content, faculty selection, and/or faculty presentations, and, therefore, does not compromise the scientific integrity of the educational activity.
Discussion of off-label product usage and/or off-label product use is made at the sole discretion of the faculty. Off-label product discussion and usage is not endorsed by the Cardiovascular Research Foundation or the conference directors of this activity.
Faculty participating in continuing medical education activities sponsored by the Cardiovascular Research Foundation are required to disclose to the activity audience any real or apparent conflicts of interest related to the content of their presentations. Faculty not complying with this policy are not permitted to participate in this activity.
FACULTY DISCLOSURE SUMMARY
KEY: (G/R) Grant Support/Research Contract (C/H/S) Consultant Fee/Honoraria/Speaker’s Bureau (E) Equity (R/I) Royalty/Intellectual Property Rights (S) Salary/Salary Support (O) Other Financial Benefit
A. Pieter Kappetein: (G/R) Abbott Vascular, Medtronic, Edwards Lifesciences
Brij Maini: (G/R) Abbott Vascular, Medtronic, Baylis (C/H/S) Abbott Vascular, Medtronic,
Christopher U. Meduri: (G/R) Medtronic (C/H/S) Boston Scientific Corp., Medtronic
Michael J. Reardon: (C/H/S) Medtronic
Nicolas M. Van Mieghem: (G/R) Abbott Vascular, Boston Scientific Corp., Medtronic, Claret (C/H/S) Claret
Planning Committee
Arielle Gelardi (Planner)
(S) Cardiovascular Research Foundation
ACTIVITY SPONSORSHIP AND SUPPORT
This program is sponsored by the Cardiovascular Research Foundation. It is supported through an educational grant from Medtronic Inc. and was developed without influence from commercial supporters.
HOW TO RECEIVE CME CREDIT
To obtain CME credit for this activity, participants must review all CME information, view all presentations in their entirety, and complete the Activity Evaluation Form. If you have any questions, please contact Arielle Gelardi at agelardi@crf.org